Cranberry-derived OTC UTI treatment found to be as effective as Rx antibiotic
KEARNY, N.J. A recent study published in the Journal of Antimicrobial Chemotherapy, a peer-reviewed publication, has found that the administration of Cran-Max was comparable to the commonly prescribed antibiotic, trimethoprim, for the prevention of recurrent urinary tract infections in older women.
“Our trial is the first to evaluate cranberry (Cran-Max) in the prevention of recurrent UTIs specifically in older women, and the first head-to-head double-blind comparison of cranberry versus antibiotic prophylaxis,” stated )Proprietary Nutritionals, which markets Cran-Max. “Trimethoprim had a very limited advantage over cranberry extract (Cran-Max) in the prevention of recurrent UTIs in older women and had more adverse effects.”
“This is a landmark study for Cran-Max and the nutritional supplement industry demonstrating the benefits of a natural product for prevention,” stated Sherry Torkos, author of The Benefits of Berries. “Prevention of UTI with antibiotics is effective but undesirable due to side effects, most commonly diarrhea, upset stomach and yeast infection.”
“Antimicrobial resistance is another concern,” said Torkos. “In fact, resistance to trimethoprim in bacteria causing UTIs has been steadily increasing in Northern European and American countries from as high as 15 percent in the 1970s to about 24 percent in 2004.”
“This study comes on the heels of another landmark study sponsored by a European government agency that commenced in 2005 on 560 women which will be completed this month,” stated Dean Mosca, president of Proprietary Nutritionals. “It compares Cran-Max to a 480 mg dose of trimethoprim-sulfamethoxazole for a one-year period. A comprehensive body of science is developing for Cran-Max as an efficacious, recommended UTI preventative by medical professionals,” he said.
Urinary tract infections are the most common infection in older adults, and the second most common infection in women.
GSI Commerce, GNC agree to extend e-commerce partnership
PITTSBURGH, Pa. GSI Commerce and GNC on Tuesday announced a multiyear extension and expansion of the e-commerce agreement between the two companies. Under the agreement, which runs through 2017, GSI will continue to provide GNC’s online store with e-commerce technology, order management and customer care operations.
“Since partnering with GSI, our online business has become an important channel for both product sales and information,” said Beth Kaplan, president and chief merchandising and marketing officer for GNC. “We are excited about extending our e-commerce agreement with GSI and expanding our relationship to include interactive marketing services.”
In addition to e-commerce services, the agreement names GSI’s digital agency, gsi interactive, as GNC’s digital agency of record and adds a full complement of marketing services that include site usability testing, paid search marketing, comparison shopping engines, affiliate marketing, display advertising, emerging media, and e-mail services powered by e-Dialog, GSI’s e-mail marketing subsidiary.
“We are very happy that GNC will continue to build its online business with GSI as its e-commerce partner,” said Scott Hardy, executive vice president of business management for GSI. “This long-term, multiyear, and expanded agreement speaks to the success of the relationship and to the opportunity in front of us for continued growth.”
GNC launched its online store on GSI’s e-commerce platform in the fourth quarter of 2005. Online sales have since become an important channel for GNC as well as a valuable extension of its brand, the company stated.
3M completes acquisition of Futuro health hosiery line
ST. PAUL, Minn. 3M on Tuesday announced that it has completed its acquisition of the Futuro health supports and compression hosiery product line from Beiersdorf.
Terms of the transaction were not disclosed.
The acquisition marries two venerable brands in the first aid/sports support products space. Futuro’s complete line of therapeutic and sport supports—wraps, braces and elastic bandages—provide compression support and heat retention as well as stability to relieve symptoms associated with minor sprains, strains, arthritis and muscle pain.
Futuro’s compression hosiery products include therapeutic and anti-embolism stockings. Futuro health supports and Futuro compression hosiery products are sold through consumer channels, including drug stores, mass merchandisers and grocers in North America, and pharmacies internationally.
And 3M already has a number of high-performance products under its Nexcare brand to help people heal—from braces for the knee, wrist, ankle and back, to products for after surgery care, skin care and athletic wraps under its broad line of Nexcare branded bandage and first aid products.